Results 51 to 60 of about 830,673 (331)

Recombinant GPI-anchored TIMP-1 stimulates growth and migration of peritoneal mesothelial cells. [PDF]

open access: yes, 2012
Mesothelial cells are critical in the pathogenesis of post-surgical intraabdominal adhesions as well as in the deterioration of the peritoneal membrane associated with long-term peritoneal dialysis.
Elfriede Noessner   +43 more
core   +2 more sources

Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. [PDF]

open access: yesPLoS ONE, 2012
In radically resected gastric cancer the possibility to predict the site of relapse could be clinically relevant for the selection of post-surgical management.
Mario Scartozzi   +13 more
doaj   +1 more source

Late-onset meningeal metastases in liposarcoma: A case report and review of the literature [PDF]

open access: yes, 2006
Intracranial metastases from liposarcoma are rare and almost always preceded by the development of systemic tumour spread. We report here a case of liposarcoma with spread to the cranial nervous system 23 years after treatment of the primary tumour.
White, J.   +3 more
core   +1 more source

Colorectal cancer peritoneal metastases: Biology, treatment and next steps

open access: yes, 2020
The presence of peritoneal metastases in patients with advanced colorectal cancer is associated with poor prognosis but the mechanisms for this are unclear.
Baaten, ICPA   +4 more
core   +1 more source

Epidemiological Study of New Cases of Peritoneal Metastases

open access: yesZhongliu Fangzhi Yanjiu, 2022
Peritoneal metastases (PM) are defined as the primary or secondary occurrence/progression of malignant tumor in peritoneum. PM were previously thought to be a terminal disease without effective treatment, with short survival and poor prognosis.
YANG Rui   +5 more
doaj   +1 more source

The BUMPy road of peritoneal metastases in ovarian cancer.

open access: yesDiagnostic and Interventional Imaging, 2022
Ovarian cancer is the most common cause of death due to gynecologic malignancies, with more than 70% of patients presenting with advanced stage disease at the time of diagnosis.
S. Nougaret   +7 more
semanticscholar   +1 more source

Peritoneal regression grading score (PRGS) in peritoneal metastasis: how many biopsies should be examined?

open access: yesPleura and Peritoneum, 2022
The four-tied peritoneal regression grading score (PRGS) is increasingly used to evaluate the response of peritoneal metastases (PM) to chemotherapy. The minimal number of peritoneal biopsies needed for PRGS determination remains unclear.
Solass Wiebke   +5 more
doaj   +1 more source

The molecular biology of peritoneal metastatic disease

open access: yesEMBO Molecular Medicine, 2023
Peritoneal metastases are a common form of tumor cell dissemination in gastrointestinal malignancies. Peritoneal metastatic disease (PMD) is associated with severe morbidity and resistance to currently employed therapies.
Sanne Bootsma   +2 more
doaj   +1 more source

CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases

open access: yesGut
Background Peritoneal metastasis is the most common metastasis pattern of gastric cancer. Patients with gastric cancer peritoneal metastasis (GCPM) have a poor prognosis and respond poorly to conventional treatments. Recently, immune checkpoint blockade (
Yuan-Fang Li   +19 more
semanticscholar   +1 more source

The Accuracy of the Surgical Peritoneal Cancer Index in Patients with Peritoneal Metastases of Colorectal Cancer

open access: yesDigestive Surgery, 2021
Introduction: The peritoneal cancer index (PCI) is one of the most important prognostic factors in patients with peritoneal metastases from colorectal cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC).
N. D. de Boer   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy